Advertisement

Topics

Bayer begins Phase III programme of vilaprisan to treat uterine fibroids

19:00 EDT 3 Jul 2017 | Net Resources International

Bayer has started a Phase III ASTEROID clinical programme of vilaprisan with enrolment of the first patient for treatment of uterine fibroids.

Original Article: Bayer begins Phase III programme of vilaprisan to treat uterine fibroids

NEXT ARTICLE

More From BioPortfolio on "Bayer begins Phase III programme of vilaprisan to treat uterine fibroids"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...